OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-10.51%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$322M
AUM Growth
+$322M
(-29%)
Cap. Flow
-$51.5M
Cap. Flow
% of AUM
-16.01%
Top 10 Holdings %
Top 10 Hldgs %
95.49%
Holding
18
New
2
Increased
3
Reduced
5
Closed
3
Top Buys
| 1 |
MOTS
Motus GI Holdings, Inc. Common Stock
MOTS
|
$8.63M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.45M |
| 3 |
CFRX
ContraFect Corporation
CFRX
|
$2.25M |
| 4 |
Soleno Therapeutics
SLNO
|
$2.13M |
| 5 |
AXDX
Accelerate Diagnostics
AXDX
|
$125K |
Top Sells
| 1 |
Pacific Biosciences
PACB
|
$50.5M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$8.83M |
| 3 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$4.85M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$3.4M |
| 5 |
VRAY
ViewRay, Inc.
VRAY
|
$2.03M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
QuidelOrtho
QDEL
$1.95B
| $92.9M | 28.82% | 1,903,558 | – | – |
|
|
AMRN
2
Amarin Corp
AMRN
$311M
| $70.8M | 21.96% | 5,201,580 -648,571 | -11% | -$8.83M |
|
|
AXDX
3
DELISTED
Accelerate Diagnostics
AXDX
| $48.3M | 14.97% | 4,198,022 +10,877 | +0.3% | +$125K |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $35M | 10.86% | 471,500 -45,735 | -9% | -$3.4M |
|
|
5
Pacific Biosciences
PACB
$393M
| $18.9M | 5.87% | 2,557,764 -6,829,870 | -73% | -$50.5M |
|
6
Opko Health
OPK
$1.1B
| $11.1M | 3.44% | 3,686,194 | – | – |
|
|
CFRX
7
DELISTED
ContraFect Corporation
CFRX
| $8.75M | 2.71% | 5,719,772 +1,469,388 | +35% | +$2.25M |
|
|
MOTS
8
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $8.63M | 2.68% | +2,775,000 | New | +$8.63M |
|
|
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.45M | 2% | +174,535 | New | +$6.45M |
|
|
10
Soleno Therapeutics
SLNO
$3.6B
| $6.3M | 1.95% | 3,683,195 +1,245,135 | +51% | +$2.13M |
|
|
BIOL
11
DELISTED
Biolase, Inc.
BIOL
| $6.11M | 1.9% | 6,173,250 | – | – |
|
|
AGEN
12
Agenus
AGEN
$133M
| $3.23M | 1% | 1,358,918 -140,622 | -9% | -$335K |
|
|
VRML
13
DELISTED
Vermillion, Inc.
VRML
| $2.95M | 0.91% | 9,825,289 | – | – |
|
14
Biogen
BIIB
$19.4B
| $1.93M | 0.6% | 6,368 | – | – |
|
|
ADAP
15
Adaptimmune Therapeutics
ADAP
$15.6M
| $304K | 0.09% | 52,921 -844,573 | -94% | -$4.85M |
|
|
EPZM
16
DELISTED
Epizyme, Inc
EPZM
| – | – | -28,884 | Closed | -$306K |
|
|
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – | -111,542 | Closed | -$820K |
|
|
VRAY
18
DELISTED
ViewRay, Inc.
VRAY
| – | – | -216,862 | Closed | -$2.03M |
|